G. P. Breitbach

Surgery in Recurrent Ovarian Cancer: The Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) DESKTOP OVAR Trial

Philipp Harter, Andreas du Bois, Maik Hahmann et al. · Annals of Surgical Oncology · 2006 · 422 citations

Medicine, Oncology, Surgery +16

A Risk Model for Secondary Cytoreductive Surgery in Recurrent Ovarian Cancer: An Evidence-Based Proposal for Patient Selection

Wen‐Juan Tian, S. Dennis, Jalid Sehouli et al. · Annals of Surgical Oncology · 2011 · 128 citations

Medicine, Gynecology, Surgery +17

Neoadjuvant Chemotherapy Shows Similar Response in Patients With Inflammatory or Locally Advanced Breast Cancer When Compared With Operable Breast Cancer: A Secondary Analysis of the GeparTrio Trial Data

Serban Dan Costa, Sibylle Loibl, Manfred Kaufmann et al. · Journal of Clinical Oncology · 2009 · 72 citations · Full text

Medicine, Oncology, Pharmacology +13

Dose-Intensive Epirubicin-Based Chemotherapy Is Superior to an Intensive Intravenous Cyclophosphamide, Methotrexate, and Fluorouracil Regimen in Metastatic Breast Cancer: A Randomized Multinational Study

Stephen P. Ackland, Antonio Antón, G. P. Breitbach et al. · Journal of Clinical Oncology · 2001 · 57 citations

Medicine, Oncology, Pharmacology +17

Randomised trial: survival benefit and safety of adjuvant dose-dense chemotherapy for node-positive breast cancer

Sherko Kümmel, J. Krocker, A. Kohls et al. · British Journal of Cancer · 2006 · 53 citations · Full text

Medicine, Oncology, Pharmacotherapy +17